QUINTILES IMS HOLDINGS, INC. (NYSE:Q) Files An 8-K Entry into a Material Definitive Agreement
Item1.01
| Entry into a Material Definitive Agreement. |
On February23, 2017, Quintiles IMS Holdings, Inc. (the Company)
entered into a Share Repurchase Agreement (the Agreement) with
certain of its principal shareholders: certain funds affiliated
with TPG Global, LLC (TPG), certain funds affiliated with Leonard
Green Partners, L.P. (LGP), and Dr.DennisB. Gillings and certain
of his affiliates (DG Shareholders) (the Sellers). to the
Agreement, the Company has agreed to purchase, and the Sellers
have agreed to sell, an aggregate of 9,677,420 shares of the
Companys common stock, par value $0.01 per share, in a private
transaction for an aggregate purchase price of approximately $750
million, subject to satisfaction of a financing condition on or
prior to March3, 2017. The shares being sold include 7,561,013
shares from TPG, 1,116,407 shares from LGP and 1,000,000 shares
from the DG Shareholders.
The description of the Agreement contained herein is qualified in
its entirety by reference to the Agreement, a copy of which is
attached hereto as Exhibit 10.1 and incorporated herein by
reference.
This private repurchase transaction of the Company shares was
effected to the Companys existing repurchase program (the
Repurchase Program) approved by the Companys board of directors.
As of today, the Company has remaining authorization to
repurchase up to approximately $750 million of Company shares
under the existing Repurchase Program, after giving effect to
repurchase of shares to the Agreement.
Certain relationships of the Sellers with the Company are
described under Certain Relationships and Related Person
Transactions in the Companys proxy statement dated February22,
2017.
| Item9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
See the Exhibit Index attached hereto.
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
| Item9.01 | Financial Statements and Exhibits. |
(d)Exhibits
| 10.1 |
Share Repurchase Agreement, dated as of February23, 2017, between Quintiles IMS Holdings, Inc. and the selling shareholders identified therein. |
About QUINTILES IMS HOLDINGS, INC. (NYSE:Q)
Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies. Its segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions. QUINTILES IMS HOLDINGS, INC. (NYSE:Q) Recent Trading Information
QUINTILES IMS HOLDINGS, INC. (NYSE:Q) closed its last trading session 00.00 at 78.12 with 1,954,538 shares trading hands.